STRO · Company research
Sutro Biopharma, Inc. (STRO): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 14.45 | $210,625,915.5 | 136943915.5 | 39.6388888888888889 | — | — | 14.5029205742615162 | — | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.